VAERS Explorer
Back to explore

Report #2862763

Received Oct 2, 2025

Hospitalized
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
FL
Recovered
Recovered
Vaccinated
—
Onset
Jan 1, 2025
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH4GJ3274—

Symptoms (3)

COVID-19Platelet countPlatelet count decreased

Symptom narrative

platelet count rose to 70/75 K/ul and then dropped back to 50/60 K/uL; covid; This is a spontaneous report received from a Consumer or other non HCP. An 87-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Lot number: GJ3274) for covid-19 immunisation; BNT162b2 (BNT162B2), on 11Jan2021 as dose 1, single (Lot number: EK9231), on 01Feb2021 as dose 2, single (Lot number: EL8982) and on 21Aug2021 as dose 3 (booster), single (Lot number: FC3181) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (hospitalization) with onset Jan2025, outcome "recovered" (2025), described as "covid"; PLATELET COUNT ABNORMAL (hospitalization), outcome "unknown", described as "platelet count rose to 70/75 K/ul and then dropped back to 50/60 K/uL". The clinical course was reported as follows: for over 20 years patients' platelet count had been in the 50 to 60 K/uL range. During the Pfizer vaccines injections (2021 to 2023) his platelet count rose to 70/75 K/uL and then dropped back to 50/60 K/uL. During his Jan2025 5-day hospital for COVID his platelet blood count also rose to 75 K/uL an all-time high. The patient was currently under Hematology treatment as his platelet count fell to 19 K/uL causing his hematologist to order platelet infusions (platelet count now 35 K/uL after 3 infusions). The patient was also scheduled to begin a 5 day and then 23-day stop of cedazuridine, decitabine (INQOVI) 35mg tablet along with antibiotics, anti virals and antifungals. The patient was hospitalized for covid-19 (hospitalization duration: 5 day(s)). The patient underwent the laboratory tests and procedures: as aforementioned. Therapeutic measures were taken as a result of platelet count abnormal.

Lab data

Test Name: Platelet count; Result Unstructured Data: Test Result:70/75 K; Comments: u/L rose; Test Name: Platelet count; Result Unstructured Data: Test Result:50/60 K; Comments: uL dropped back; Test Name: Platelet count; Result Unstructured Data: Test Result:50 to 60 K; Comments: uL usual range; Test Name: Platelet count; Result Unstructured Data: Test Result:19 K; Comments: uL; Test Name: Platelet count; Result Unstructured Data: Test Result:35 K; Comments: uL after 3 platelet infusions